These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 30062077)

  • 21. Upper tract urothelial carcinoma following intravesical bacillus Calmette-Guérin therapy for nonmuscle-invasive bladder cancer: Results from a multi-institutional retrospective study.
    Nishiyama N; Hotta H; Takahashi A; Yanase M; Itoh N; Tachiki H; Miyao N; Matsukawa M; Kunishima Y; Taguchi K; Kitamura H; Masumori N
    Urol Oncol; 2018 Jun; 36(6):306.e9-306.e15. PubMed ID: 29550096
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tuberculous epididymitis following intravesical Bacillus Calmette-Guérin immunotherapy.
    Hoag N; Pommerville PJ; Kibsey PC; Cavers DJ; Eddy RJ
    Can J Urol; 2009 Apr; 16(2):4589-91. PubMed ID: 19364433
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Miliary tuberculosis following intravesical Bacillus Calmette and Guérin therapy: A rare complication of a frequent procedure.
    Loued L; Fahem N; Kaddoussi R; Abdelaaly M; Cheikh Mhamed S; Rouatbi N
    Urol Case Rep; 2021 Sep; 38():101655. PubMed ID: 33868941
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Combination of Intravesical Bacille Calmette-Guérin and Chemotherapy vs. Bacille Calmette-Guérin Alone in Non-muscle Invasive Bladder Cancer: A Meta-Analysis.
    Huang D; Jin YH; Weng H; Huang Q; Zeng XT; Wang XH
    Front Oncol; 2019; 9():121. PubMed ID: 30881921
    [No Abstract]   [Full Text] [Related]  

  • 25. Epididymo-orchitis following intravesical bacillus Calmette-Guérin therapy.
    Menke JJ; Heins JR
    Ann Pharmacother; 2000 Apr; 34(4):479-82. PubMed ID: 10772435
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Left Anterior Descending Coronary Artery and Multiple Peripheral Mycotic Aneurysms Due to Mycobacterium Bovis Following Intravesical Bacillus Calmette-Guerin Therapy: A Case Report.
    Duvnjak P; Laguna M
    J Radiol Case Rep; 2016 Aug; 10(8):12-27. PubMed ID: 27761190
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tuberculous epididymo-orchitis secondary to Bacillus Calmette-Guérin (BCG) in non-muscular invasive bladder cancer.
    Lara Moscoloni LF; Santarelli M; Spagnuolo J
    Urol Case Rep; 2021 Jul; 37():101629. PubMed ID: 33796443
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Bilateral tuberculous epididymitis after intravesical Bacillus Calmette-Guerin therapy].
    Shigehara K; Kobori Y; Amano T; Takemae K
    Hinyokika Kiyo; 2005 Dec; 51(12):839-42. PubMed ID: 16440736
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Tuberculous epididymitis after Bacillus Calmette-Guérin intravesical therapy : a case report].
    Uno T; Numazaki S; Kato N; Egawa S
    Hinyokika Kiyo; 2014 Jun; 60(6):291-4. PubMed ID: 25001646
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Microscopic detection of bacillus Calmette-Guérin mycobacteria in bladder biopsy using fluorescence
    Loukil A; Baron SA; Argemi X; Maubon T; Eldin C
    New Microbes New Infect; 2021 Jan; 39():100826. PubMed ID: 33425363
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Case report: Mycobacterium bovis orchitis post intravesical Bacillus Calmette Guerin.
    Samannodi M; Villavicencio A; Zhao A; Chavez V; Ericsson CD
    IDCases; 2018; 14():e00465. PubMed ID: 30479960
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intravesical bacillus Calmette-Guerin versus mitomycin C for Ta and T1 bladder cancer.
    Shelley MD; Court JB; Kynaston H; Wilt TJ; Coles B; Mason M
    Cochrane Database Syst Rev; 2003; (3):CD003231. PubMed ID: 12917955
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Update on the Dutch Cooperative Trial: mitomycin versus bacillus Calmette-Guérin-Tice versus bacillus Calmette-Guérin RIVM in the treatment of patients with pTA-pT1 papillary carcinoma and carcinoma in situ of the urinary bladder. Dutch South East Cooperative Urological Group.
    Witjes WP; Witjes JA; Oosterhof GO; Debruyne MJ
    Semin Urol Oncol; 1996 Feb; 14(1 Suppl 1):10-6. PubMed ID: 8727805
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intravesical instillation of epirubicin, bacillus Calmette-Guerin and bacillus Calmette-Guerin plus isoniazid for intermediate and high risk Ta, T1 papillary carcinoma of the bladder: a European Organization for Research and Treatment of Cancer genito-urinary group randomized phase III trial.
    van der Meijden AP; Brausi M; Zambon V; Kirkels W; de Balincourt C; Sylvester R;
    J Urol; 2001 Aug; 166(2):476-81. PubMed ID: 11458050
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bacille Calmette-Guérin (BCG) spondylitis with adjacent mycotic aortic aneurysm after intravesical BCG therapy: a case report and literature review.
    Kusakabe T; Endo K; Nakamura I; Suzuki H; Nishimura H; Fukushima S; Yamamoto K
    BMC Infect Dis; 2018 Jun; 18(1):290. PubMed ID: 29954321
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intravesical Therapy for the Treatment of Nonmuscle Invasive Bladder Cancer: A Systematic Review and Meta-Analysis.
    Chou R; Selph S; Buckley DI; Fu R; Griffin JC; Grusing S; Gore JL
    J Urol; 2017 May; 197(5):1189-1199. PubMed ID: 28027868
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The first case of bacillus Calmette-Guérin-induced small-vessel central nervous system vasculitis.
    Parent ME; Richer M; Liang P
    Clin Rheumatol; 2018 Aug; 37(8):2297-2302. PubMed ID: 29740727
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mycobacterial brain tuberculomas due to Bacille Calmette-Guérin intravesical chemotherapy for bladder cancer: A case report and literature review.
    Golub V; Malhotra P; Patel S
    Can J Infect Dis Med Microbiol; 2011; 22(3):104-6. PubMed ID: 22942888
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Should intravesical Bacillus Calmette-Guerin (BCG) treatment be administered to patients with T0 after repeat transurethral resection of bladder tumor in patients with high-risk non-muscle invasive bladder cancer?
    Yuk HD; Jeong CW; Kwak C; Kim HH; Ku JH
    PLoS One; 2018; 13(11):e0208267. PubMed ID: 30496283
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Peritoneal and pulmonary tuberculosis following intravesical administration of Bacillus Calmette-Guérin for bladder cancer.
    Uematsu R; Teishima J; Sakata H; Mita Y; Yoshii T; Tashiro Y; Yao A; Nakamura I
    Int Cancer Conf J; 2023 Jul; 12(3):221-225. PubMed ID: 37251014
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.